Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Medical Devices U.K. Government Partners with Motif Neurotech for Advanced BCI Development
news pictures (9)

U.K. Government Partners with Motif Neurotech for Advanced BCI Development

24th February 2025

The U.K.’s Advanced Research and Invention Agency (ARIA) has awarded a substantial multi-million dollar grant to Motif Neurotech to propel the development of a pioneering therapeutic brain-computer interface (BCI). This initiative aims to create a non-invasive neural device network capable of monitoring and regulating cognitive and psychiatric conditions. By focusing on simplifying implantation procedures, this venture promises to revolutionise mental health treatments, potentially benefiting countless patients.

Motif Neurotech, a Houston-based neurotechnology company, is taking a significant leap forward with its innovative treatment platform, targeting mood, attention, and sleep-related conditions. The brain, recognised for its electrical nature, is now seen as a promising focal point for therapeutic intervention. By leveraging a network of millimetre-sized, wireless implants, Motif aims to support brain activity regulation with high precision. The collaboration with various research partners, including the U.K. startup MintNeuro and faculty from Rice University, enriches this ambitious project. Their collective expertise will focus on miniaturising the neural devices and optimising wireless data transmission, potentially setting new standards within the medical industry.

This collaboration between ARIA and Motif Neurotech signals a transformative shift in mental health treatment methodologies through neurotechnology. The simplicity and rapidity of the proposed implantation process, combined with targeted cell-type stimulation, offer the promise of effective treatments with minimal side effects. As Motif advances its clinical development of the DOT to combat treatment-resistant depression, this initiative could redefine therapeutic approaches in neuropsychiatry worldwide.

For the latest updates and in-depth insights into the world of Medical Devices, including breakthrough technology, industry trends, and regulatory news, contact Holly Haynes today!

We have hundreds of jobs available across the Healthcare industry, find your perfect one now.